Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Alzheimer’s Awareness Month: A time to focus on research

November is National Alzheimer’s Disease Awareness Month. It’s a month where we stop to think about the 5.8 million Americans living with Alzheimers, ...

Continue reading

We Asked 4,000 Patients about Clinical Trials: Here's What Matters Most [Webinar Recap]

Last week, Antidote’s Head of Partnerships, Lindsey Wahlstrom-Edwards, hosted a webinar in which she shared the results of our patient survey. In the ...

Continue reading

The New Rules for Clinical Trials Patient Engagement: An ERT Podcast

Recently, Antidote’s Director of Business Development, Rachel Lind, was featured on the fantastic ERT podcast, “Trial Better.” She and host Jason ...

Continue reading

[Webinar] We Asked 4,000 Patients about Clinical Trials: Here's What Matters Most

It’s no secret that recruiting patients for clinical trials can be a difficult endeavor. And, even when a trial meets its quotas and timelines, many ...

Continue reading

Learn About Precision Recruitment at SCRS 2019

We’re gearing up to head to Florida later this week for the SCRS Site Solutions Summit, the annual meeting that brings sites, sponsors, CROs, and ...

Continue reading

Leadership Profile: An Interview with Antidote CFO Keith Lovell

Keith Lovell joined Antidote as CFO in September 2015, bringing more than 25 years of financial and commercial experience at companies ranging from ...

Continue reading

Antidote Named Scrip Award Finalist for “Best Technological Development in Clinical Trials”

The Scrip Awards are where the industry’s best and brightest are recognized for excellence across the drug development spectrum. That’s why we’re ...

Continue reading

Putting patients at the center starts with trust

A few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over ...

Continue reading

Why quality matters more than quantity in clinical trial patient recruitment

Today, nearly 60 million patients are needed for currently recruiting clinical trials. And in fact, 80% of trials will be delayed or closed due to ...

Continue reading

Webinar: "What I've Learned in 20 Years of Patient Recruitment"

As medications become more targeted and sophisticated, the growing complexity of clinical trial protocols is making it more difficult than ever to ...

Continue reading

Get our latest posts in your inbox